Janus Henderson Group
MDGL icon

Janus Henderson Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Janus Henderson Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05B Buy
2,018,647
+433,804
+27% +$207M 0.5% 35
2025
Q4 		$918M Sell
1,584,843
-257,847
-14% -$132M 0.41% 47
2025
Q3 		$845M Sell
1,842,690
-349,063
-16% -$130M 0.39% 48
2025
Q2 		$663M Sell
2,191,753
-14,096
-0.6% -$4.2M 0.33% 65
2025
Q1 		$723M Sell
2,205,849
-2,545
-0.1% -$836K 0.4% 48
2024
Q4 		$681M Sell
2,208,394
-269,766
-11% -$75.9M 0.35% 59
2024
Q3 		$526M Sell
2,478,160
-7,591
-0.3% -$1.94M 0.27% 89
2024
Q2 		$696M Sell
2,485,751
-115,531
-4% -$27.5M 0.37% 55
2024
Q1 		$695M Sell
2,601,282
-300,768
-10% -$70.9M 0.38% 50
2023
Q4 		$672M Sell
2,902,050
-140,611
-5% -$24.6M 0.4% 52
2023
Q3 		$444M Buy
3,042,661
+1,558,535
+105% +$293M 0.29% 90
2023
Q2 		$343M Buy
1,484,126
+1,108,452
+295% +$300M 0.21% 118
2023
Q1 		$91M Buy
375,674
+193,026
+106% +$52.6M 0.06% 267
2022
Q4 		$53M Buy
182,648
+96,265
+111% +$9.41M 0.04% 357
2022
Q3 		$5.61M Buy
+86,383
New +$6M ﹤0.01% 803
2018
Q4 		– Sell
-1,343
Closed -$288K – 1396
2018
Q3 		$288K Buy
1,343
+454
+51% +$114K ﹤0.01% 1387
2018
Q2 		$249K Buy
+889
New +$156K ﹤0.01% 1348

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group's MDGL Position: Q1 2026 in Review

Janus Henderson Group increased its Madrigal Pharmaceuticals (MDGL) stake by 27% in Q1 2026, buying an estimated $207M and bringing the position to 2,018,647 shares worth $1.05B. The position accounts for 0.5% of the portfolio, ranked #35.

Janus Henderson Group first reported a position in MDGL in Q2 2018 and has held it in 17 quarters since. 380 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Janus Henderson Group held 2,018,647 shares of Madrigal Pharmaceuticals worth $1.05B as of Q1 2026.
  • Janus Henderson Group bought 433,804 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $207M.
  • Madrigal Pharmaceuticals made up 0.5% of Janus Henderson Group's portfolio in Q1 2026, its #35 holding.
  • Janus Henderson Group first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 17 quarters since.
  • 380 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.